Current issues in the treatment of cytoparasitic mixed infection in cats

At the present stage of development of veterinary medicine, cytoparasitic infections of animals play a very insignificant role, although according to statistical reports of veterinary laboratories, an increase in cat diseases of chlamydial and mycoplasmal etiology is noted, which often occur in the form of a mixed infection. Such pathologies are considered as a complex process of interaction between two pathogens and the animal's body. The complexity of diagnosis and therapy of mixed infections is a very urgent problem. The regional veterinary laboratory, based on the studies of clinical material from sick cats, annually registers mixed infections, among which 26% are mixed infections, 39% of which are chlamydial-mycoplasmal. In 66% of cases, the pathology is noted in mongrel kittens under the age of one year, kept in shelters. The success of the fight against cat diseases caused by mixed infection, including and chlamydial-mycoplasmal largely depends on the correctly selected antibacterial drugs in the treatment regimens. The article discusses the diagnosis of chlamydial-mycoplasmal infection in cats and the experience of treatment using antibacterial drugs of three pharmacological groups in the regimens: fluoroquinolones (oflosan), macrolides (azithromycin) and tetracyclines (doxycycline) with established sensitivity of chlamydia and mycoplasma to them. The use of a 10% solution of oflosan (ofloxacin) for oral administration in a dose of 0.25-0.5 ml / 10 kg of body weight once a day for 21 days seems promising in the treatment regimen, as a result of which the recovery process is accelerated by 1.4 times, the cost of the course of treatment for a cat is reduced by 1.3 times.